Results 271 to 280 of about 1,571,346 (349)

Atrial‐secondary tricuspid regurgitation: a better prognosis in early stage heart failure, but not in late stage

open access: yesESC Heart Failure, EarlyView.
Atrial TR as more favourable prognosis except in advanced patients. Abstract Background and Aims Although the classification of secondary tricuspid regurgitation (STR) by atrial or ventricular aetiology (A‐STR or V‐STR) carries prognostic importance, the confounding effects of New York Heart Association (NYHA) class have not yet been elucidated.
Corentin Bourg   +9 more
wiley   +1 more source

Clinical impact of tricuspid regurgitation in patients with acute myocardial infarction

open access: yesESC Heart Failure, EarlyView.
Abstract Aims The clinical impact of tricuspid regurgitation (TR) in patients after acute myocardial infarction (AMI) is largely unknown. The aim of this study was to clarify the prevalence and prognostic impact of TR in post‐AMI patients treated with appropriate primary percutaneous coronary intervention (PCI).
Shun Nishino   +5 more
wiley   +1 more source

Cardiac arrhythmias

open access: yesJournal of the American College of Cardiology, 2000
openaire   +1 more source

Magnetocardiography for the non‐invasive diagnosis of myocardial inflammation in cardiac amyloidosis: A proof‐of‐concept study

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Myocardial inflammation is increasingly recognized for its association with impaired clinical outcomes in cardiac amyloidosis but a trend towards less invasive diagnosis impedes its detection. The aim of this study was to assess magnetocardiography (MCG) as a potential non‐invasive method to diagnose myocardial inflammation in patients ...
Maximilian Leo Müller   +13 more
wiley   +1 more source

Cardiac Arrhythmias

open access: yesJournal of the American College of Cardiology, 2007
openaire   +1 more source

Prognostic impact of peak oxygen consumption in heart failure: A systematic review and meta‐analysis

open access: yesESC Heart Failure, EarlyView.
Based on 64 studies, each 1 mL/kg/min increase in VO2peak significantly reduced all‐cause mortality (HR: 0.86, 95% CI 0.82–0.90) and combined outcomes of ventricular assist device, transplant and all‐cause mortality (HR: 0.84, 95% CI 0.79–0.89) in patients with heart failure, though no significant association was observed with cardiovascular mortality (
Konstantinos Prokopidis   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy